Company intelligence / Profile preview

Avenue Therapeutics

Bay Harbor Islands/Miami*, Florida, United Statesavenuetx.com ↗

Ownership: Public · ATXI
Employees: ~2
Development stage: Phase 2

Overview

Avenue Therapeutics is advancing a pipeline of small molecule therapies for neurologic diseases. Its lead asset AJ201 is in a Phase 1b/2a trial for SBMA/Kennedy’s Disease with topline data expected around year-end 2024. IV Tramadol has reached agreement with the FDA for a pivotal Phase 3 safety study in acute post-operative pain but requires additional funding or partnership to proceed. BAER‑101 is preclinical/early clinical and planned for further development pending financing.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

3 assets

AJ201

Phase 1b/2a

Indications: Spinal and Bulbar Muscular Atrophy

2 more assets in the full pipeline.

Request access →

Partnerships

AnnJi Pharmaceutical Co., Ltd. – partner on AJ201 clinical development(Additional partnerships not specified)

Financials

Market cap: $2.7M
Total revenue: $0
Enterprise value: $773.1K

Beyond the preview

Go deeper on Avenue Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avenue Therapeutics.

Explore the full profile